Asthma
From the Journals
In utero exposure to asthma medication not tied to risks of neurodevelopmental disorders
Data from more than 20,000 children showed no increased risk of autism, ADHD, or Tourette syndrome in children exposed to asthma medication in...
From the Journals
Sputum markers may predict remission in eosinophilic asthma
Specific sputum markers were associated with remission after interleukin-5–targeted therapy.
From the Journals
Beware risk of sedatives for respiratory patients
There has not been a systematic assessment of commonly prescribed medications with potential respiratory side-effects.
From the Journals
Dietitian-led weight loss program improves difficult-to-treat asthma in obese patients
Clinically important improvements seen in asthma control and quality of life over 16 weeks compared to usual care.
From the Journals
Frequent visits to green spaces linked to lower use of some meds
Finnish city dwellers who often visited green spaces, such as parks and community gardens, used fewer psychotropic, antihypertensive, and asthma...
From the Journals
Muscle weakness predicts poor outcomes in asthma patients
Lower muscle mass was associated with lower functional exercise capacity in adults with asthma.
From the Journals
Adult-onset asthma subtypes associated with both eosinophil, neutrophil levels
Four subtypes determined by blood eosinophil and neutrophil counts were associated with asthma severity and unique patterns of features in real-...
From the Journals
Obesity impacts peripheral airway reactivity, asthma
Overall, most obese individuals with and without asthma showed significant changes in peripheral airway resistance.
From the Journals
Defining six asthma subtypes may promote personalized treatment
A large, retrospective cohort study defined of asthma subtypes based on steroid use, health care use, and comorbidities
From the Journals
Persistent asthma linked to higher carotid plaque burden
Carotid plaque was present in half of participants without asthma but in close to 70% of participants with persistent asthma.
From the Journals
Add tezepelumab to SCIT to improve cat allergy symptoms?
“Tezepelumab is currently an expensive biologic, so it remains to be seen whether patients and payors will be willing to pay for this add-on...